This study revealed that as the grade of astrocytic tumors increases, the expression level of cyclin D1 increases as well, suggesting that cyclin D1 can promote the development of glioma and, therefore, can be used as an indicator in the judgment of the prognosis of glioma. Here, CCND1 is linked to astrocytic tumor.